Financial Times
UK · 3 hrs ago
AI scored
BioNTech to cut fifth of workforce as it winds down Covid vaccine production
78Accuracy
centreBias
0Ratings
💬 0Comments
AI Analysis
Accuracy 78/100
Partisan intensity 15/100
ObjectivePartisan
Centre / Neutral ✓ Fair headline
BioNTech plans to reduce its workforce by approximately 20% as it scales back Covid-19 vaccine production and redirects focus toward developing cancer treatments.
BioNTech to cut fifth of workforce as it winds down Covid vaccine production
German biotech is shifting towards cancer treatments
Discussion 0 comments
Sort:
?
No comments yet — be the first to start the discussion!